Jian Tang1, Shengbo Tang2, Jichun Liu1, Qicai Wu1, Li Wan1, Qirong Xu1. 1. Department of Cardiothoracic Surgery, The First Affiliated Hospital of Nanchang University Jiangxi, China. 2. Department of Oncology, The First Affiliated Hospital of Nanchang University Jiangxi, China.
Abstract
BACKGROUND/AIM: Several reports have investigated the role of exonuclease 1 (EXO1) rs1047840 in lung cancer risk in different ethnic populations. Nevertheless, the results have been controversial. We aimed to assess the possible association between EXO1 rs1047840 and risk of lung cancer in a meta-analysis. METHODS: Human hospital- or population-based studies released before December 16, 2013 were identified by systematic search of the PubMed and Embase databases. Data were extracted in duplicate from each study. An OR and 95% CI (odds ratio and 95% confidence interval) was calculated to evaluate the effects of EXO1 rs1047840 on lung carcinogenesis. RESULTS: A total of 1,114 lung cancer patients and 1,166 well-matched controls were analyzed in this study. The fixed-effects meta-analysis revealed that carriage of a single A allele, compared to the carriage of single G allele, was associated with 1.18 times increased risk of lung cancer (A vs. G: OR =1.18; 95% CI: 1.03-1.35; PHeterogeneity, 0.121). CONCLUSION: This first meta-analysis demonstrates that the A allele of EXO1 rs1047840 may confer modulating effects on the risk of lung cancer and could be used as a marker for early detection and primary prevention.
BACKGROUND/AIM: Several reports have investigated the role of exonuclease 1 (EXO1) rs1047840 in lung cancer risk in different ethnic populations. Nevertheless, the results have been controversial. We aimed to assess the possible association between EXO1rs1047840 and risk of lung cancer in a meta-analysis. METHODS:Human hospital- or population-based studies released before December 16, 2013 were identified by systematic search of the PubMed and Embase databases. Data were extracted in duplicate from each study. An OR and 95% CI (odds ratio and 95% confidence interval) was calculated to evaluate the effects of EXO1rs1047840 on lung carcinogenesis. RESULTS: A total of 1,114 lung cancerpatients and 1,166 well-matched controls were analyzed in this study. The fixed-effects meta-analysis revealed that carriage of a single A allele, compared to the carriage of single G allele, was associated with 1.18 times increased risk of lung cancer (A vs. G: OR =1.18; 95% CI: 1.03-1.35; PHeterogeneity, 0.121). CONCLUSION: This first meta-analysis demonstrates that the A allele of EXO1rs1047840 may confer modulating effects on the risk of lung cancer and could be used as a marker for early detection and primary prevention.
Authors: Brian W Kirk; Matthew Feinsod; Reyna Favis; Richard M Kliman; Francis Barany Journal: Nucleic Acids Res Date: 2002-08-01 Impact factor: 16.971
Authors: Finn Cilius Nielsen; Anne Charlotte Jäger; Anne Lützen; Jens R Bundgaard; Lene Juel Rasmussen Journal: Oncogene Date: 2004-02-19 Impact factor: 9.867
Authors: Nifang Niu; Daniel J Schaid; Ryan P Abo; Krishna Kalari; Brooke L Fridley; Qiping Feng; Gregory Jenkins; Anthony Batzler; Abra G Brisbin; Julie M Cunningham; Liang Li; Zhifu Sun; Ping Yang; Liewei Wang Journal: BMC Cancer Date: 2012-09-24 Impact factor: 4.430